We are live on
!
Find out more
Los Angeles Capital Management Portfolio holdings
AUM
$25.4B
1-Year Est. Return
38.46%
This Fund
S&P 500
This Quarter
Est. Return
+13.16%
1 Year Est. Return
+38.46%
3 Year Est. Return
+154.38%
5 Year Est. Return
+223.79%
10 Year Est. Return
+923.25%
AUM
$22.5B
AUM Growth
+$1.93B
(+9.4%)
Cap. Flow
+$256M
Cap. Flow
% of AUM
1.14%
Top 10 Holdings %
Top 10 Hldgs %
26.61%
Holding
1,346
New
164
Increased
337
Reduced
605
Closed
194
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$426M |
| 2 |
Deere & Co
DE
|
+$212M |
| 3 |
NVIDIA
NVDA
|
+$149M |
| 4 |
W.W. Grainger
GWW
|
+$140M |
| 5 |
Netflix
NFLX
|
+$135M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$196M |
| 2 |
Home Depot
HD
|
+$189M |
| 3 |
Gilead Sciences
GILD
|
+$145M |
| 4 |
Oracle
ORCL
|
+$145M |
| 5 |
Microsoft
MSFT
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.24% |
| 2 | Financials | 13.5% |
| 3 | Healthcare | 12.02% |
| 4 | Consumer Discretionary | 11.94% |
| 5 | Industrials | 11.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FISV
376
Fiserv Inc
FISV
$27.4B
| $4.05M | 0.02% |
35,836
+27,441
| +327% | +$3.02M |
|
377
Silicon Laboratories
SLAB
$7.3B
| $4.03M | 0.02% |
23,032
+19,778
| +608% | +$3.32M |
|
378
The Ensign Group
ENSG
$10.6B
| $4.02M | 0.02% |
42,077
-4,044
| -9% | -$371K |
|
379
TripAdvisor
TRIP
$1.26B
| $4.01M | 0.02% |
+202,072
| New | +$4.32M |
|
380
Ingredion
INGR
$6.54B
| $4M | 0.02% |
39,301
-15,423
| -28% | -$1.54M |
|
381
Williams Companies
WMB
$90.1B
| $3.98M | 0.02% |
133,422
-689,579
| -84% | -$21.3M |
|
382
Intercontinental Exchange
ICE
$85B
| $3.92M | 0.02% |
37,607
-3
| -0% | -$312 |
|
383
Post Holdings
POST
$3.65B
| $3.86M | 0.02% |
+42,963
| New | +$3.91M |
|
384
Guidewire Software
GWRE
$14.4B
| $3.84M | 0.02% |
+46,783
| New | +$3.4M |
|
385
Haemonetics
HAE
$4.16B
| $3.82M | 0.02% |
46,174
+38,685
| +517% | +$3.13M |
|
386
NewMarket
NEU
$8.59B
| $3.78M | 0.02% |
10,352
+105
| +1% | +$36.4K |
|
387
Liberty Media Series C
FWONK
$26B
| $3.73M | 0.02% |
+51,551
| New | +$3.49M |
|
388
Madison Square Garden
MSGS
$9.97B
| $3.72M | 0.02% |
+19,096
| New | +$3.56M |
|
389
Liberty Media Series A
FWONA
$23.7B
| $3.69M | 0.02% |
+57,025
| New | +$3.44M |
|
|
SF
390
Stifel
SF
$12.8B
| $3.66M | 0.02% |
92,888
+965
| +1% | +$40.6K |
|
391
Henry Schein
HSIC
$10.1B
| $3.64M | 0.02% |
44,668
-690
| -2% | -$56.2K |
|
392
Marriott International
MAR
$92.5B
| $3.62M | 0.02% |
21,798
+85
| +0.4% | +$14.2K |
|
393
CoStar Group
CSGP
$12.4B
| $3.62M | 0.02% |
52,522
-6,041
| -10% | -$446K |
|
394
AMN Healthcare
AMN
$1.26B
| $3.61M | 0.02% |
43,502
-10,116
| -19% | -$952K |
|
395
Diamondback Energy
FANG
$56.2B
| $3.5M | 0.02% |
25,902
-106,305
| -80% | -$14.8M |
|
396
GE Aerospace
GE
$379B
| $3.45M | 0.02% |
45,222
-94,302
| -68% | -$6.31M |
|
397
Qiagen
QGEN
$8.88B
| $3.44M | 0.02% |
+70,729
| New | +$3.6M |
|
398
Rockwell Automation
ROK
$50.1B
| $3.43M | 0.02% |
11,703
+10,803
| +1,200% | +$3.07M |
|
399
American Financial Group
AFG
$12B
| $3.43M | 0.02% |
28,251
-11,320
| -29% | -$1.49M |
|
400
DaVita
DVA
$11.6B
| $3.43M | 0.02% |
+42,247
| New | +$3.39M |
|
Similar funds
VAI
Los Angeles Capital Management's Q1 2023 Portfolio in Review
As of Q1 2023, Los Angeles Capital Management held 1,346 positions worth $22.5B, up 9.4% from $20.6B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Los Angeles Capital Management's Q1 2023 filing shows 164 new, 337 increased, 605 reduced and 194 closed positions. Its largest new stake was Bio-Rad Laboratories Class A: 184,796 shares worth $88.5M. The largest sale was Pfizer, an estimated $196M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 28% a quarter earlier, followed by Financials and Healthcare.
- Los Angeles Capital Management's largest Q1 2023 buy was Bio-Rad Laboratories Class A: 184,796 shares worth $88.5M.
- Los Angeles Capital Management added most to Visa in Q1 2023, an estimated $426M increase.
- Los Angeles Capital Management's biggest Q1 2023 reduction was Pfizer, cutting an estimated $196M.
- Los Angeles Capital Management fully exited Regions Financial in Q1 2023, selling an estimated $50.4M.
- Los Angeles Capital Management's ten largest holdings make up 27% of its $22.5B portfolio in Q1 2023.
- Los Angeles Capital Management opened 164 new positions and closed 194 in Q1 2023.
- Los Angeles Capital Management's portfolio value rose 9.4% quarter-over-quarter to $22.5B.
Based on Los Angeles Capital Management's 13F filing for Q1 2023, filed 4 May 2023.